Impact of the 2018 Japan floods on asthma prescriptions: A longitudinal analysis
Journal of Allergy and Clinical Immunology: Global · 2027-01 · 6 (1) · 100792
DOI: 10.1016/j.jacig.2026.100792 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Allergy and Clinical Immunology: Global, 2027-01. Verfasst von Hanae Konishi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular and Internal Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The impact of flood disasters on adult asthma is poorly understood.
Objective
This study aimed to investigate the impact of the 2018 Japan floods on new prescriptions for asthma controller medications and treatments for asthma exacerbations in adults.
Methods
This retrospective longitudinal analysis used data from the National Database of Health Insurance Claims and Specific Health Checkups for residents of regions severely affected by the 2018 Japan floods, covering 1 year before and 1 year after the disaster. New asthma controller prescriptions were compared between officially certified disaster victims and nonvictims with no controller use in the preceding year. Among prior controller users, prescriptions for short-acting β 2 -agonists and oral corticosteroids were compared between victims and nonvictims.
Results
Among 5,000,129 participants, 31,235 were disaster victims. Victims had a higher incidence of new asthma controller prescriptions than nonvictims (adjusted hazard ratio, 1.47; 95% CI, 1.38-1.57). This increase was observed across all age groups and was greater in younger and middle-aged adults. A difference-in-differences analysis showed increased short-acting β 2 -agonist prescriptions at 3, 5, 7, and 11 months after the disaster and increased oral corticosteroid prescriptions at 5 months among victims.
Conclusions
Victims of the 2018 Japan floods had increased prescriptions for new-onset and exacerbated asthma, suggesting an association between flood disasters and increased adult asthma-related health care needs.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Molecular and Internal Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
- Department of Community-Based Medical Systems, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
- Department of General Internal Medicine, Hiroshima University Hospital, Hiroshima, Japan.
- Department of Emergency and Critical Care Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Zitieren
APA
Konishi, H., Yoshida, S., Iwamoto, H., Horimasu, Y., Utsumi, S., Ohshimo, S., Hattori, N., & Matsumoto, M. (2027). Impact of the 2018 Japan floods on asthma prescriptions: A longitudinal analysis. Journal of Allergy and Clinical Immunology: Global, 6(1), 100792. https://doi.org/10.1016/j.jacig.2026.100792
Vancouver
Konishi H, Yoshida S, Iwamoto H, Horimasu Y, Utsumi S, Ohshimo S, et al. Impact of the 2018 Japan floods on asthma prescriptions: A longitudinal analysis. Journal of Allergy and Clinical Immunology: Global. 2027;6(1):100792. doi:10.1016/j.jacig.2026.100792
BibTeX
@article{Konishi2027,
author = {Konishi, Hanae and Yoshida, Shuhei and Iwamoto, Hiroshi and Horimasu, Yasushi and Utsumi, Shu and Ohshimo, Shinichiro and Hattori, Noboru and Matsumoto, Masatoshi},
title = {Impact of the 2018 Japan floods on asthma prescriptions: A longitudinal analysis},
journal = {Journal of Allergy and Clinical Immunology: Global},
year = {2027},
volume = {6},
number = {1},
pages = {100792},
doi = {10.1016/j.jacig.2026.100792}
}
EUVIMED